Effects of neoadjuvant chemotherapy on operative adverse events and chemotherapy and radiotherapy in patients undergoing immediate breast reconstruction.

CONCLUSIONS: NAC remains likely to contribute to increased postoperative AEs in patients undergoing IBR; however, it does not affect postoperative treatment and IBR is appropriate for patients undergoing NAC.
PMID: 32162180 [PubMed - as supplied by publisher]

Source: Breast Cancer - March 10, 2020 Category: Cancer & Oncology Authors: Adachi Y, Okumura S, Sawaki M, Hattori M, Yoshimura A, Gondo N, Kotani H, Iwase M, Kataoka A, Sugino K, Horisawa N, Ozaki Y, Endo Y, Sakamoto S, Iwata H Tags: Breast Cancer Source Type: research